These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4751259)

  • 41. Influence of mitotic cycle inhibitors on the antileukemic activity of cytosine arabinoside (NSC-63878) in mice bearing leukemia L1210.
    Vadlamudi S; Goldin A
    Cancer Chemother Rep; 1971 Dec; 55(5):547-55. PubMed ID: 5159846
    [No Abstract]   [Full Text] [Related]  

  • 42. Therapy of acute myelocytic leukemia. Daunomycin contrasted with a combination of cytosine arabinoside and 6-thioguanine.
    Poth JL; Johnson PK; George RP; Schrier SL
    Calif Med; 1972 Dec; 117(6):1-11. PubMed ID: 4508367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activity of cytosine arabinoside (NSC-63878) in a spectrum of rodent tumors.
    Wodinsky I; Kensler CJ
    Cancer Chemother Rep; 1965 Aug; 47():65-8. PubMed ID: 5829428
    [No Abstract]   [Full Text] [Related]  

  • 44. Letter: Proposed new derivative of cytosine arabinoside (NSC-63878) to circumvent resistance.
    Cysyk RL
    Cancer Chemother Rep; 1974; 58(3):298-9. PubMed ID: 4842665
    [No Abstract]   [Full Text] [Related]  

  • 45. [Acute refractory lymphoblastic leukemia in the adult. Treatment with daunorubicin, cytosine arabinoside, 6-thioguanine, vincristine and prednisone].
    Marín P; Grañena A; Carreras E; Ribera JM; Rozman C
    Sangre (Barc); 1984; 29(6):987-92. PubMed ID: 6598237
    [No Abstract]   [Full Text] [Related]  

  • 46. Suppression by cytosine arabinoside of serum-blocking factors of cell-mediated immunity to syngeneic transplants of mouse mammary tumors.
    Heppner GH; Calabresi P
    J Natl Cancer Inst; 1972 Apr; 48(4):1161-7. PubMed ID: 5023677
    [No Abstract]   [Full Text] [Related]  

  • 47. Daunorubicin (NSC-82151), vincristine (NSC-67574), cytosine arabinoside (NSC-63878), and prednisone (NSC-10023) combination therapy for advanced adult acute leukemia.
    Burns CP
    Cancer Chemother Rep; 1975; 59(4):757-60. PubMed ID: 1100227
    [No Abstract]   [Full Text] [Related]  

  • 48. Sequential chemotherapy with cyclophosphamide (NSC-26271) and cytosine arabinoside (NSC-63878) in mice with advanced leukemia L1210.
    Hoffman GS; Kline I; Gang M; Tyrer DD; Goldin A; Mantel N; Venditti JM
    Cancer Chemother Rep; 1969 Oct; 53(5):265-71. PubMed ID: 5377613
    [No Abstract]   [Full Text] [Related]  

  • 49. [Cytosine arabinoside in the polychemotherapy of acute leukemia].
    Mandelli F
    Minerva Med; 1972 Mar; 63(24):1436-44. PubMed ID: 4502506
    [No Abstract]   [Full Text] [Related]  

  • 50. Approaches to combination chemotherapy in rat, mouse, and hamster tumors.
    Griswold DP; Dykes DJ; Kelley CA; Roberts BJ; Dominick CA
    Cancer Chemother Rep 2; 1974 Mar; 4(1):99-108. PubMed ID: 4524043
    [No Abstract]   [Full Text] [Related]  

  • 51. Letter: Chemotherapy for erythroleukemia.
    Bluming A
    N Engl J Med; 1974 Aug; 291(8):419-20. PubMed ID: 4603175
    [No Abstract]   [Full Text] [Related]  

  • 52. Sequencing of cytosine arabinoside (NSC-63878) and daunorubicin (NSC-82151) in acute myelogenous leukemia.
    Omura GA
    Cancer Treat Rep; 1976 May; 60(5):629-31. PubMed ID: 1068745
    [No Abstract]   [Full Text] [Related]  

  • 53. Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia.
    Yates JW; Wallace HJ; Ellison RR; Holland JF
    Cancer Chemother Rep; 1973; 57(4):485-8. PubMed ID: 4586956
    [No Abstract]   [Full Text] [Related]  

  • 54. Combinations of tetrahydrouridine and cytosine arabinoside in mouse tumors.
    Kreis W; Hession C; Soricelli A; Scully K
    Cancer Treat Rep; 1977 Oct; 61(7):1355-64. PubMed ID: 589601
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction therapy and intensive consolidation with daunorubicin, cytosine arabinoside, and 6-thioguanine in adult acute nonlymphoblastic leukemia.
    Cassileth PA; Kahn SB; Silber R; Weiler C
    Cancer Clin Trials; 1981; 4(2):125-8. PubMed ID: 7249250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute myelomonocytic leukemia in a dog.
    Rohrig KE
    J Am Vet Med Assoc; 1983 Jan; 182(2):137-41. PubMed ID: 6572189
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo synchrony of solid B16 melanoma by cytosine arabinoside, an inhibitor of DNA synthesis.
    Gibson MH; Bertalanffy FD
    J Natl Cancer Inst; 1972 Oct; 49(4):1007-18. PubMed ID: 5084119
    [No Abstract]   [Full Text] [Related]  

  • 58. Burkitt's lymphoma--a model for intensive chemotherapy.
    Ziegler JL; Deisseroth AB; Applebaum FR; Graw RG
    Semin Oncol; 1977 Sep; 4(3):317-23. PubMed ID: 335519
    [No Abstract]   [Full Text] [Related]  

  • 59. [Abnormalities of the erythropoiesis at the beginning of remission in acute promyelocytic leukemia treated with arabinoside-cytosine].
    Dubois-Ferrière H; Aguercif M; Hazeghi P; Rudhardt M
    Schweiz Med Wochenschr; 1970 Feb; 100(7):321-3. PubMed ID: 5263342
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of acute myeloid leukemia in the young and adult with aracytin and thioguanine].
    Gansl RC; Cabral E; Gomes Filho JM; Silveira PA; Gualandro SF; Zanichelli MA; Pozzi D
    Rev Hosp Clin Fac Med Sao Paulo; 1979; 34(5):207-10. PubMed ID: 297263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.